Cart
sales@molnova.com
Home - Products - Others - Other Targets - Mexenone

Mexenone

CAS No. 1641-17-4

Mexenone( —— )

Catalog No. M12487 CAS No. 1641-17-4

Mexenone (Uvistat, benzophenone-10) is a benzophenone-derived sunscreening agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
100MG 31 In Stock
200MG Get Quote In Stock
500MG 69 In Stock
1G 100 In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Mexenone
  • Note
    Research use only, not for human use.
  • Brief Description
    Mexenone (Uvistat, benzophenone-10) is a benzophenone-derived sunscreening agent.
  • Description
    Mexenone (Uvistat, benzophenone-10) is a benzophenone-derived sunscreening agent.(In Vitro):Mexenone (48 h) has an LC50 of 1.5 mg/L of D. japonica and has an LC50 of 0.9 mg/L of D. magnaby Ecosar.
  • In Vitro
    Mexenone (48 h) has an LC50 of 1.5 mg/L of D. japonica and has an LC50 of 0.9 mg/L of D. magnaby Ecosar.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1641-17-4
  • Formula Weight
    242.28
  • Molecular Formula
    C15H14O3
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    COC1=CC(O)=C(C=C1)C(=O)C1=CC=C(C)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Torres V, Correia T. Contact Dermatitis. 1991 Aug;25(2):126-7.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Disitamab vedotin

    Disitamab vedotin (RC-48) is a newly developed antibody-active molecule conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), consisting of hertuzumab coupled to monomethyl auristatin E (MMAE) via a cleavable linker.

  • Cgp 29030A

    CGP 29030A is a new piperazine derivative with analgesic activity and significant inhibitory effect on potentially nociceptive dorsal horn neurons, which can be used to study painful disorders.

  • Tirzepatide TFA

    Tirzepatide TFA (LY3298176 TFA) is a disaccharide dependent insulin peptide (GIP) and glucagon-like peptide-1 (glp-1) receptor agonist.

Sign In Join Free